ACECLOFENAC-INDUCED ANAPHYLACTIC SHOCK: A RARE BUT LIFE-THREATENING ADVERSE DRUG REACTION
Authors/Creators
- 1. Pharm D Intern, TVM College of Pharmacy, Ballari, Karnataka, India – 583101.
- 2. V Pharm D, TVM College of Pharmacy, Ballari, Karnataka, India – 583101.
- 3. Pharm D graduate, KSPC Registered Pharmacist, Ballari, Karnataka, India – 583101.
Description
Aceclofenac is a widely prescribed nonsteroidal anti-inflammatory drug (NSAID) used in the management of pain and inflammatory disorders. Although generally considered safe and well tolerated, rare but severe hypersensitivity reactions such as anaphylactic shock may occur and can be life-threatening without prompt treatment. We report the case of a 39-year-old female who developed acute abdominal pain, irritability and hypotension shortly after ingesting oral aceclofenac for pain relief. On presentation, her blood pressure was 90/60 mmHg with maintained oxygen saturation. Laboratory investigations showed mild leukocytosis and elevated inflammatory markers, and she had no prior history of drug allergy. The close temporal association between drug intake and symptom onset suggested aceclofenac-induced anaphylaxis. Immediate discontinuation of the drug was undertaken, and the patient was treated with intramuscular adrenaline as first-line therapy, followed by intravenous corticosteroids, antihistamines and supportive care, resulting in rapid hemodynamic stabilization and complete recovery. Causality assessment using WHO–UMC criteria categorized the reaction as Probable/Likely, and the Naranjo Adverse Drug Reaction Probability Scale also indicated a Probable association. This case emphasizes the importance of early recognition, prompt adrenaline administration, structured causality assessment and pharmacovigilance reporting to prevent recurrence and improve patient safety.
Files
18 WJPSR 2123.pdf
Files
(989.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:e62cc250216281b83f9da5bde59c673f
|
989.6 kB | Preview Download |
Additional details
References
- 1. Iolascon G, Giménez S, Mogyorósi D. A review of aceclofenac: analgesic and anti-inflammatory effects on musculoskeletal disorders. J Pain Res, 2021; 14: 3651–3663.
- 2. Harsh Singh Rajput. Mechanism of Action of Aceclofenac. PharmacyFreak.com [Internet]. 4 Oct 2025 [cited 2026 Feb 10]. Available from: https://pharmacyfreak.com/mechanism-of-action-of-aceclofenac/
- 3. Akkus Arslan Ş, Tirnaksiz F. A nonsteroidal antiinflammatory drug: aceclofenac. FABAD J Pharm Sci, 2010; 35: 105–118.
- 4. Bushra R, Shoaib MH, Naeem MI, Aslam N. Aceclofenac: a new effective and safe NSAID. Int J Drug Dev Res (IJDDT), 2013; 4(1): 34–42.
- 5. Ameen KHN, Pinninti R, Jami S. Aceclofenac-induced Stevens–Johnson syndrome/toxic epidermal necrolysis overlap syndrome. J Pharmacol Pharmacother, 2013; 4(1).
- 6. Johnson RF, Peebles RS Jr. Anaphylactic shock: pathophysiology, recognition, and treatment. Semin Respir Crit Care Med, 2004; 25(6): 695–703.
- 7. Patel TK, Patel PB, Barvaliya MJ, Tripathi CB. Drug-induced anaphylactic reactions in Indian population: a systematic review. Indian J Crit Care Med, 2014; 18(12).
- 8. Brown AFT. Anaphylactic shock: mechanisms and treatment. J Accid Emerg Med, 1995; 12: 89–100.